A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may ...
This ECG demonstrates an “extensive anterior” and “tombstoning” of the ST segment seen during a large acute anterior myocardial infarction. This is usually the result of thrombosis of the ...
Increase in NAION associated with semaglutide use among individuals with type 2 diabetes. (HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly ...
In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...
The study findings suggest a possible link between semaglutide use and an increased risk of NAION in patients with diabetes.
Patients with diabetes who take semaglutide are at increased risk for NAION compared with patients who do not use GLP-1 RAs to control their blood sugar, a new study finds.
The results of this cohort study suggest that semaglutide use was associated with an increased risk of nonarteritic anterior ischemic ...
1mon
HealthDay on MSNNonarteritic Anterior Ischemic Optic Neuropathy Increased With SemaglutideWEDNESDAY, Feb. 26, 2025 (HealthDay News) -- For individuals with type 2 diabetes (T2D), semaglutide is associated with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results